BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Doxorubicin
,
rs2476601
,
IL1A
,
T cell receptor signaling pathway
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
immunotoxin ha22
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.
Deamidation in Moxetumomab Pasudotox Leading to Conformational Change and Immunotoxin Activity Loss.
Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its Use.
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Ce…
Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and M…
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immu…
Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
LMB-2 to Treat Hairy Cell Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ